Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study.
- Published in:
- BMC Immunology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12865-025-00693-9
- By:
- Publication type:
- Article
Works matching AU Rombach, S. M.
Results: 3
1
2
Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome.
- Published in:
- Current Medical Literature: Lysosomal Storage Disease, 2013, v. 11, n. 2, p. 63
- By:
- Publication type:
- Article
3
Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine.
- Published in:
- Current Medical Literature: Lysosomal Storage Disease, 2013, v. 11, n. 2, p. 54
- By:
- Publication type:
- Article